ARTV
Price
$3.21
Change
-$0.06 (-1.83%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
76.99M
82 days until earnings call
SLXN
Price
$7.74
Change
+$0.48 (+6.61%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
5.66M
Interact to see
Advertisement

ARTV vs SLXN

Header iconARTV vs SLXN Comparison
Open Charts ARTV vs SLXNBanner chart's image
Artiva Biotherapeutics
Price$3.21
Change-$0.06 (-1.83%)
Volume$400
Capitalization76.99M
Silexion Therapeutics
Price$7.74
Change+$0.48 (+6.61%)
Volume$300
Capitalization5.66M
ARTV vs SLXN Comparison Chart in %
Loading...
ARTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARTV vs. SLXN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a StrongBuy and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ARTV: $3.27 vs. SLXN: $7.26)
Brand notoriety: ARTV and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 63% vs. SLXN: 19%
Market capitalization -- ARTV: $76.99M vs. SLXN: $5.66M
ARTV [@Biotechnology] is valued at $76.99M. SLXN’s [@Biotechnology] market capitalization is $5.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, ARTV is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 5 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • ARTV’s TA Score: 5 bullish, 3 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ARTV is a better buy in the short-term than SLXN.

Price Growth

ARTV (@Biotechnology) experienced а +20.66% price change this week, while SLXN (@Biotechnology) price change was +6.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Reported Earning Dates

ARTV is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTV($77M) has a higher market cap than SLXN($5.66M). ARTV YTD gains are higher at: -67.560 vs. SLXN (-75.920). SLXN has higher annual earnings (EBITDA): -17.81M vs. ARTV (-79.07M). ARTV has more cash in the bank: 142M vs. SLXN (3.47M). SLXN has less debt than ARTV: SLXN (3.7M) vs ARTV (13.2M). ARTV (0) and SLXN (0) have equivalent revenues.
ARTVSLXNARTV / SLXN
Capitalization77M5.66M1,361%
EBITDA-79.07M-17.81M444%
Gain YTD-67.560-75.92089%
P/E RatioN/AN/A-
Revenue00-
Total Cash142M3.47M4,097%
Total Debt13.2M3.7M357%
TECHNICAL ANALYSIS
Technical Analysis
ARTVSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
35%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
22%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
28%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
27%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
53%
Declines
ODDS (%)
Bearish Trend 9 days ago
84%
Bearish Trend 8 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 4 days ago
38%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASEKY15.53N/A
N/A
Aisin Corporation
FBPA24.27N/A
N/A
Farmers Bank of Appomattox (VA)
MCHB41600.00N/A
N/A
Mechanics Bank of Richmond (CA)
PLTYF0.02N/A
N/A
Plastec Technologies, Ltd.
FDMIF2.60-0.02
-0.84%
FOUNDERS METALS INC.

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been loosely correlated with TNFA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTV jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
+15.14%
TNFA - ARTV
47%
Loosely correlated
+15.53%
ERAS - ARTV
35%
Loosely correlated
-1.25%
GBIO - ARTV
34%
Loosely correlated
+3.59%
CELC - ARTV
34%
Loosely correlated
+1.01%
RLYB - ARTV
33%
Loosely correlated
-1.16%
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+0.83%
IMA - SLXN
63%
Loosely correlated
+0.07%
CELC - SLXN
50%
Loosely correlated
+1.01%
MRSN - SLXN
43%
Loosely correlated
-0.26%
CHRS - SLXN
26%
Poorly correlated
+0.88%
QSI - SLXN
25%
Poorly correlated
-0.85%
More